IvyCap Ventures sells stake in Pharmarack at 104 pc IRR
IvyCap Ventures sells stake in Pharmarack at 104 pc IRR Homegrown VC fund IvyCap had invested Rs 21 crore in B2B healthcare platform Pharmarack in 2019. 0 claps Homegrown venture capital (VC) fund IvyCap Ventures on Monday announced the sale of its stake in business-to-business (B2B) healthcare platform Pharmarack at an annual internal rate of return (IRR) of 104 percent. IvyCap had invested Rs 21 crore in Pharmarack in 2019. Pharmarack combines technology, analytics, logistics, supply chain, and financing and is an ecosystem partner for pharmaceutical and consumer health companies, distr...